期刊文献+

脐血浆培养的脐血树突状细胞对胃癌细胞的特异杀伤作用 被引量:5

The specific cytotoxic effects to gastric cancer cells induced by human cord blood dendritic cells cultured with human umbilical cord plasma
下载PDF
导出
摘要 目的尝试用脐血浆代替胎牛血清培养脐血树突状细胞(DCs),并使之负载胃癌抗原,观察其对胃癌细胞的特异杀伤作用。方法分离脐血单个核细胞(CBMCs)并在含10%同源脐血浆的培养体系中诱导培养,部分细胞加入胃癌冻融抗原冲击。流式细胞仪检测细胞表面抗原CD1a和CD83表达,MTT法检测DCs体外刺激淋巴细胞增殖活性,LDH法检测DCs诱导的细胞毒T淋巴细胞(CTLs)对胃癌及肝癌细胞的细胞毒作用。结果CBMCs能分化为表型正常的未成熟DCs,并进而吞噬胃癌细胞冻融抗原成熟,刺激淋巴细胞增殖并诱导对胃癌细胞株特异的CTLs毒性。结论脐血浆培养的脐血DCs能有效捕获胃癌冻融抗原,激发针对胃癌细胞的特异杀伤效应。本实验采用的DCs制备方法具有方法简单、成本较低、瘤苗制备时间较短等优点。 Objective To evaluate the effect of replacing fetal cattle serum with umbilical cord plasma on incubating dendritic cells (DCs) from umbilical cord blood in vitro and observe the anti-tumor response to gastric cancer cells induced by DCs after impacted with freeze thawing antigen. Methods Human cord blood mononuclear cells (CBMCs) were cultured in RPMI1640 containing 10% autologous plasma, some of which were supplemented with tumor lyaates. The cells were shown by flow cytometry to express CD1a and CD83. MTT assay was applied to measure allostimulate capacity of DCs. Killing rates of autologous T lymphocytes induced by DCs on different target cells were measured by LDH method, Results Cells appeared typical phenotype of DCs after culture. The tumor lysate antigens could be captured by DCs and then presented to lymphocytes successfully to stimulate the proliferation. The cytotoxic T lymphocytes (CTLs) response in vitro was enhanced by treating with tumor lysates. Conclusion The DCs can capture the antigen utility and induce the specific cytotoxic effects to gastric cancer cells. The method to incubate DCs in this study is simple, low-cost and short-time.
出处 《福建医药杂志》 CAS 2009年第4期79-81,共3页 Fujian Medical Journal
关键词 脐血浆 树突状细胞 胃癌 瘤苗 Umbilical cord plasma Dendritic cells Gastric cancer Tumor vaccination
  • 相关文献

参考文献8

  • 1Piemonti L, Monti P, Zerbi A, et al. Generation and functional characterization of dendritic cells from patients with pancreatic carcinoma with special regard to clinical applicability[J]. Cancer Immunol Immunother, 2000, 49 (10) : 544-550,.
  • 2Kuroki H, Morisaki T, Matsumoto K, et al. Streptococcal preparation OK-432: a new maturation factor of monocyte-derived dendritic cells for clinical use [J]. Cancer Immunol Immunother, 2003, 52 (9): 561-568.
  • 3Yu JS, Liu G, Ying WH, et al. Vaccination with tumor lysatepulsed dendritic cells elicits antigen-specific cytotoxic T-cells in patients with malignant glioma [J]. Cancer Res, 2004, 64 (14): 4973-4979.
  • 4Caux C, Vanbervliet B, Massacrier C, et al. CD34+ hematopoietic Progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSFq-TNF alpha [J]. J Exp Med, 1996, 184 (8): 695-706.
  • 5Chaux P, Favre N, Martin M, et al. Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and induoible B7 expression in rats [J]. Int J Cancer, 1997, 72 (4): 619-624.
  • 6Opsjln SL, Wathen NC, Tingulstad S, et al. Tumor necrosis factor, interleukin-1, and interleukin-6 in normal human pregnancy [J]. Am J Obstet Gynecol, 1993, 169 (2 Pt 1) : 397-404.
  • 7陈静琦,曾波航,黄慧,吕嘉春.脐血来源树突状细胞的培养鉴定[J].广州医学院学报,2003,31(4):68-72. 被引量:2
  • 8练诗梅,王晓波,薛祖光,张旗,孙健,荒木弘一.脐血来源树突状细胞的体外诱导及扩增[J].中国实验血液学杂志,2004,12(5):615-619. 被引量:3

二级参考文献18

  • 1Zheng Z, Takahashi M, Narita M, et al. Generation of dendritic cells from adherent cells of cord blood by culture with granulocytemacrophage colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha. J Hematother Stem Cell Res, 2000; 9: 45
  • 2Caux C, Vanbervliet B, Massacrier C, et al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF + TNF alpha. J Exp Med, 1996; 184:695-706
  • 3Steen R, Tjonnfjord GE, Egeland T. Comparison of the phenotype and clonogenicity of normal CD34 + cells from umbilical cord blood,granulocyte colony-stimulating factor-mobilized peripheral blood, and adult human bone marrow. J Hematother, 1994; 3: 253- 26
  • 4Ito T, Amakawa R, Inaba M, et al. Differential regulation of human blood dendritic cell subsets by IFNs. J Immunol, 2001; 166:2961 - 2969
  • 5Mitani H, Araki H. Monocyte-derived dendritic cells. Saishin Igaku 1999; 54:2626-2630
  • 6Fritsch G, Stimpfl M, Kurz M, et al. The composition of CD34 subpopulations differs beween bone marrow, blood and cord blood.Bone Marrow Transplant, 1996; 17: 169- 178
  • 7Barbosa IL, de Sousa ME, Godinho MI, et al. Analysis of surface markers on CD34+ cells, isolated from cord blood and G-CSF primed peripheral blood. Bone Marrow Transplant, 1998; 22 Suppl 1:s56
  • 8Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. 1 Morphology, quantitation, tissue distribution. J Exp Med, 1973; 137: 1142- 1162
  • 9Hart DN: Dendritic cells: unique leukocyte populations which control the primary immune response. Blood, 1997; 90: 3245- 3287
  • 10Zhou LJ, Tedder TF. CD14 + blood monocytes can differentiate into functionally muture CD83 + dendritic cells. Proc Natl Acad Sci USA, 1996; 93: 2588 - 2592

共引文献2

同被引文献46

  • 1姚俊,杨欢,高宏君.热休克蛋白在肿瘤免疫中的研究进展[J].中国医疗前沿,2008,3(15):34-36. 被引量:1
  • 2王林华,陈明.原发性高血压与内皮功能研究进展[J].心血管病学进展,2006,27(1):60-63. 被引量:23
  • 3鞠晓红,赵珍谊,方芳,马爱新.人脐血贴壁层细胞对脐血造血细胞体外扩增的作用[J].中国组织工程研究与临床康复,2007,11(7):1280-1281. 被引量:4
  • 4Amy M.Hicks,Gregory Riedlinger,Mark C.Willingham,et al.Transferable anticancer innate immunity in spontaneous regression complete resistance mice.PNAS.2006;103(20):7753-7758.
  • 5Gattinoni L,Powell DJ Tr,Rosenberg SA,et al.Adoptive immunotherapy for cancer:building on success.Nat Rev Immunol.2006;6(5):383-393.
  • 6Williams LM,Rudensky AY.Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3.Nat Immunol.2007;8(3):277-284.
  • 7Tesniere A,Panaretakis T,Kepp O,Apetoh L,Ghiringhelli F,Zitvogel L,Kroemer G.Molecular characteristics of immunogenic cancer cell death.Cell Death Differ.《 2008;15(1):3-12.
  • 8Rescigno M,Avogadri F,Curigliano G.Challenges and prospects of immunotherapy as cancer treatment.Biochim Biophys Aeta.2007;1776(1):108-123.
  • 9McKee MD,Roszkowski JJ,Nishimura MI.T cell avidity and tumor recognition:implications and therapeutic strategies.J Transl Med.2005;3:35.
  • 10June CH.Adoptive T cell therapy for cancer in the clinic.J Clin Invest.2007;117(6):1466-1476.

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部